On the last day, the Amanta Healthcare IPO was subscribed 82.60 times overall, the retail quota 54.96 times, the QIB 35.86 times, and the NII quota 209.40 times, respectively.
Details About Amanta Healthcare IPO
Amanta Healthcare got approval from SEBI for an IPO of ₹126 crores. This IPO consists of a fresh issue of ₹126 crores with a face value of ₹10 each. Moreover, the company has set up a price band between ₹120 to ₹126 per share.
In this IPO, a total of 119 shares were available in 1 lot sizes for the minimum Retail category, and for the maximum retail category,1,547 shares in 13 lot sizes. While S-HNI (Min) total of 1,666 shares in 14-lot sizes. B-HNI Minimum 7,973 shares in 67 lot sizes.
To invest in this IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum investment of ₹14,994 and maximum investment of ₹1,94,922.
- Small HNI (S-HNI): Minimum investment of ₹2,09,916.
- B-HNI Minimum: Maximum investment of ₹10,04,598.
Subscription Duration of the Amanta Healthcare IPO
The Amanta Healthcare IPO opening date was September 1, 2025, and the closing date was September 3, 2025.
The allotment of Amanta Healthcare was finalized on September 4, 2025, while the IPO listing is on September 9, 2025.
About Amanta Healthcare
Amanta Healthcare Limited is a leading pharmaceutical company that started in December 1994. It makes and sells a wide range of sterile liquid products, mainly parenterals (medicines given by injection). The company uses advanced technologies like Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) to pack its products in plastic containers. Some of the main products it makes include IV fluids, diluents, eye drops, and respiratory care solutions used in fluid therapy.
Amanta Healthcare also produces irrigation solutions, first-aid items, and eye lubricants under its medical devices segment. The company markets its products through three business divisions: National Sales, International Sales, and Product Partnerships with various Indian and foreign pharmaceutical companies.
Financial Background of Amanta Healthcare IPO
In 2025, Amanta Healthcare earned a revenue of ₹276 crores, which is slightly less than the ₹282 crores it made in 2024. However, the company’s profit increased from ₹3.63 crores in 2024 to ₹10.50 crores in 2025.
